Hong Kong has said it will delay shipments of AstraZeneca's Covid-19 vaccine this year amid mounting concerns over possible links between the shot and very rare cases of blood clots.
It had ordered 7.5 million doses from the British-Swedish company, which were scheduled to arrive in the second half of 2021.
Health Secretary Sophia Chan said the global financial centre had a sufficient supply of vaccines, with a total of 15 million doses of the Pfizer-BioNTech jab and China's Sinovac - the only two vaccines available in the city. "Even if we have signed a pre-purchase agreement with AstraZeneca, we believe that AstraZeneca vaccines will not need to be supplied to Hong Kong this year, so as not to cause a waste when the vaccine is still in